JP5302197B2 - 両親媒性コポリマーおよび調節放出の有効成分を基にした微小粒子、ならびにこれらを含む医薬製剤 - Google Patents

両親媒性コポリマーおよび調節放出の有効成分を基にした微小粒子、ならびにこれらを含む医薬製剤 Download PDF

Info

Publication number
JP5302197B2
JP5302197B2 JP2009525938A JP2009525938A JP5302197B2 JP 5302197 B2 JP5302197 B2 JP 5302197B2 JP 2009525938 A JP2009525938 A JP 2009525938A JP 2009525938 A JP2009525938 A JP 2009525938A JP 5302197 B2 JP5302197 B2 JP 5302197B2
Authority
JP
Japan
Prior art keywords
group
microparticles
polymer
solution
pharmaceutical formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009525938A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009544759A5 (zh
JP2009544759A (ja
Inventor
アラン・コンスタンシス
ヨー−ピン・チャン
Original Assignee
フラメル・テクノロジーズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フラメル・テクノロジーズ filed Critical フラメル・テクノロジーズ
Publication of JP2009544759A publication Critical patent/JP2009544759A/ja
Publication of JP2009544759A5 publication Critical patent/JP2009544759A5/ja
Application granted granted Critical
Publication of JP5302197B2 publication Critical patent/JP5302197B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2009525938A 2006-07-28 2007-07-30 両親媒性コポリマーおよび調節放出の有効成分を基にした微小粒子、ならびにこれらを含む医薬製剤 Expired - Fee Related JP5302197B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0653191A FR2904219B1 (fr) 2006-07-28 2006-07-28 Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant
FR0653191 2006-07-28
PCT/EP2007/006722 WO2008025425A1 (fr) 2006-07-28 2007-07-30 Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant

Publications (3)

Publication Number Publication Date
JP2009544759A JP2009544759A (ja) 2009-12-17
JP2009544759A5 JP2009544759A5 (zh) 2010-09-16
JP5302197B2 true JP5302197B2 (ja) 2013-10-02

Family

ID=37814390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009525938A Expired - Fee Related JP5302197B2 (ja) 2006-07-28 2007-07-30 両親媒性コポリマーおよび調節放出の有効成分を基にした微小粒子、ならびにこれらを含む医薬製剤

Country Status (11)

Country Link
EP (1) EP2049085A1 (zh)
JP (1) JP5302197B2 (zh)
KR (1) KR101407033B1 (zh)
CN (1) CN101568328B (zh)
BR (1) BRPI0714943A2 (zh)
CA (1) CA2661567C (zh)
FR (1) FR2904219B1 (zh)
IL (1) IL196426A (zh)
MX (1) MX2009000951A (zh)
WO (1) WO2008025425A1 (zh)
ZA (1) ZA200900929B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2934161B1 (fr) * 2008-07-28 2010-09-17 Flamel Tech Sa Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules.
FR2940619B1 (fr) * 2008-12-31 2012-02-10 Flamel Technologies Sa Composition comprenant un actif de solubilite aqueuse faible ou moyenne
FR2954325B1 (fr) 2009-12-23 2012-02-03 Flamel Tech Sa Polymere amphiphile fonctionnalise par la methionine
JP4829351B2 (ja) * 2010-02-05 2011-12-07 ナノキャリア株式会社 易崩壊型ポリマーミセル組成物
CN102232932B (zh) * 2010-04-27 2013-06-05 重庆莱美药业股份有限公司 果胶-阿霉素轭合物的冻干制剂及制备方法
CN102657843A (zh) * 2012-06-05 2012-09-12 云南民族大学 抗菌肽组合物及其制备方法
CN103483583B (zh) * 2013-09-24 2015-11-18 昆明理工大学 一种ε-聚赖氨酸的制备方法
WO2015151103A1 (en) * 2014-04-03 2015-10-08 Biondvax Pharmaceuticals Ltd. Compositions of multimeric-multiepitope influenza polypeptides and their production
AU2015338717B2 (en) 2014-10-31 2018-12-20 Glaxosmithkline Intellectual Property Development Limited Powder formulation
KR101891715B1 (ko) * 2016-01-15 2018-08-27 연세대학교 산학협력단 바이러스 감염의 치료용 폴리아미노산 기반의 생체환경 감응형 나노입자
WO2018025699A1 (ja) * 2016-08-02 2018-02-08 日本化薬株式会社 アクティブターゲティング型高分子誘導体、その高分子誘導体を含む組成物、及びそれらの用途
CN110483785B (zh) * 2019-07-01 2020-05-19 中山大学 一种三嵌段聚合物、载药纳米胶束、纳米药物及其制备方法和应用
CN110343245B (zh) * 2019-07-16 2021-09-28 天津大学 一种ε-聚赖氨酸-接枝-疏水氨基酸-接枝-海藻糖的糖肽及制备方法
CN112553759A (zh) * 2020-11-30 2021-03-26 福建凤竹纺织科技股份有限公司 一种多功能海藻纤维针织面料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4002736A1 (de) * 1990-01-31 1991-08-01 Hoechst Ag Biologisch abbaubare polymere, verfahren zu ihrer herstellung und verwendung derselben fuer depotzubereitungen mit kontrollierter wirkstoffabgabe
US5250293A (en) * 1991-04-22 1993-10-05 Gleich Gerald J Method for the treatment of hypersensitivity diseases by administration of anionic polymers
GB9221329D0 (en) * 1992-10-10 1992-11-25 Delta Biotechnology Ltd Preparation of further diagnostic agents
DE4407898A1 (de) * 1994-03-09 1995-09-14 Hoechst Ag Nanopartikel, enthaltend einen Wirkstoff und ein Polyketalweinsäureamid, Verfahren zu ihrer Herstellung und Verwendung derselben
DK1071407T3 (da) * 1999-01-18 2014-10-20 Lg Life Sciences Ltd Lipofile mikropartikler indeholdende et proteinlægemiddel eller et antigen og formulering omhandlende samme
FR2814951B1 (fr) * 2000-10-06 2003-01-17 Flamel Tech Sa Suspension colloidale de particules submicroniques de vectorisation de principes actifs hydrophiles (insuline) et leur mode de preparation
WO2003035051A2 (en) * 2001-10-19 2003-05-01 Inhale Therapeutic Systems, Inc. The use of proton sequestering agents in drug formulations
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
FR2862541B1 (fr) * 2003-11-21 2007-04-20 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interferons et leurs applications therapeutiques
FR2862535B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee d'interleukines et leurs applications therapeutiques

Also Published As

Publication number Publication date
IL196426A (en) 2014-07-31
KR101407033B1 (ko) 2014-06-20
CA2661567A1 (fr) 2008-03-06
CN101568328A (zh) 2009-10-28
CA2661567C (fr) 2016-09-20
WO2008025425A1 (fr) 2008-03-06
AU2007291577A1 (en) 2008-03-06
WO2008025425B1 (fr) 2008-05-02
MX2009000951A (es) 2009-02-04
FR2904219A1 (fr) 2008-02-01
WO2008025425A8 (fr) 2009-04-16
WO2008025425A9 (fr) 2008-06-12
ZA200900929B (en) 2010-06-30
EP2049085A1 (fr) 2009-04-22
CN101568328B (zh) 2012-09-05
KR20090054976A (ko) 2009-06-01
BRPI0714943A2 (pt) 2013-05-21
FR2904219B1 (fr) 2010-08-13
JP2009544759A (ja) 2009-12-17
IL196426A0 (en) 2009-09-22

Similar Documents

Publication Publication Date Title
JP5302197B2 (ja) 両親媒性コポリマーおよび調節放出の有効成分を基にした微小粒子、ならびにこれらを含む医薬製剤
US20080102128A1 (en) Modified-release microparticles based on amphiphilic copolymer and on active principles(s) and pharmaceutical formulations comprising them
JP5351015B2 (ja) （複数の）活性成分の徐放のための医薬製剤、ならびに特に治療上のその適用
USRE46686E1 (en) Pharmaceutical formulations for the prolonged release of active principle(s), and their applications, especially therapeutic applications
JP4988352B2 (ja) 有効成分の放出の延長のための薬学的調製物およびその適用、特に治療学的適用
JP2010513407A (ja) 連続脂質相中のポリアミノ酸の分散液
ZA200603959B (en) Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof
JP2005529888A (ja) 有効成分を送達するためのサブミクロン粒子のコロイド懸濁液およびその調製方法
JP2010526040A (ja) 高分子電解質および活性成分を基にした放出制御粒子および該粒子を含む製剤
MXPA06005719A (es) Formulaciones farmaceuticas para la liberacion prolongada de interleuquinas y sus aplicaciones terapeuticas.
JP5733551B2 (ja) ナノコンポジット粒子およびその製造方法
WO2007116965A1 (ja) グラフトポリマーとカルシウム化合物とを含む微粒子
JP5098225B2 (ja) 親水性活性物質含有微粒子の製造方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100727

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100727

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121011

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121016

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130110

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130416

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130521

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130620

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees